About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 463 record(s)
Req # A-2022-000636
Adverse Drug Reactions (ADRs). Report numbers: E2B_05321271, E2B_05321376, E2B_05321393, E2B_05321428, E2B_05321561, E2B_05321572, E2B_05321580, E2B_05322364, E2B_05322373, E2B_05322380.Organization: Health Canada
October 2022
Req # A-2022-000637
Adverse Drug Reactions (ADRs). Report numbers: E2B_04965656, E2B_04972403, E2B_04978406, E2B_04978770, E2B_04978800, E2B_04978806, E2B_04978817, E2B_04978937, E2B_04983032, E2B_05036944.Organization: Health Canada
October 2022
Req # A-2022-000638
Adverse Drug Reactions (ADRs). Report numbers: E2B_05322386, E2B_05326615, E2B_05332796, E2B_05338335, E2B_05338367, E2B_05338395, E2B_05338399, E2B_05338404, E2B_05338434, E2B_05338463.Organization: Health Canada
October 2022
Req # A-2022-000639
Adverse Drug Reactions (ADRs). Report numbers: E2B_05344450, E2B_05042365, E2B_05042396, E2B_05065420, E2B_05082770, 943061, 943071, 943242, 943477, 943609.Organization: Health Canada
October 2022
Req # A-2022-000640
Adverse Drug Reactions (ADRs). Report numbers: E2B_05036951, E2B_05036956, E2B_05036958, E2B_05036962, E2B_05037008, E2B_05042371, E2B_05042384, E2B_05042403, E2B_05042408, E2B_05043181.Organization: Health Canada
October 2022
Req # A-2022-000649
Adverse Drug Reactions (ADRs). Report numbers: E2B_05228350, E2B_05235142, E2B_05268562, E2B_05275943, E2B_05281084, E2B_05282897, E2B_05285081, E2B_05287079, E2B_05287293, E2B_05288711.Organization: Health Canada
October 2022
Req # A-2022-000678
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107367-394.Organization: Health Canada
October 2022
Req # A-2022-000696
Adverse Drug Reactions (ADRs). Report numbers: E2B_05381469, E2B_05419680, E2B_05387920, E2B_05380058, E2B_03759473, 00993529, E2B_05249038, 00993392, E2B_03460056, 00991741.Organization: Health Canada
October 2022
Req # A-2022-000701
Adverse Drug Reactions (ADRs). Report numbers: E2B_05298056, E2B_00999346, E2B_03561674, E2B_02768701, E2B_05354467, E2B_04921453, E2B_05377509, E2B_04308961, E2B_04308811, E2B_04809458.Organization: Health Canada
October 2022
Req # A-2022-000725
Adverse Drug Reactions (ADRs). Report numbers: E2B_05505633, E2B_05482738, E2B_05424802, 000997301, 000996688, 000999421, 000996650, 000997960, E2B_04899434 and E2B_04899441.Organization: Health Canada
October 2022